Tolbutamide as a model drug for the study of enzyme induction and enzyme inhibition in the rat
Open Access
- 1 March 1984
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 81 (3) , 557-562
- https://doi.org/10.1111/j.1476-5381.1984.tb10109.x
Abstract
The effects of various drugs on the pharmacokinetics of tolbutamide have been examined in the rat. Phenobarbitone pretreatment caused a significant decrease in half life and area under the curve (AUC) and a significant increase in clearance and volume of distribution (Vd). Acute administration of primaquine significantly increased half life and AUC and decreased clearance. In contrast, the related animoquinolone chloroquine, was without effect. Acute administration of cimetidine produced similar changes to primaquine but of lesser magnitude. Formation of the major metabolite hydroxytolbutamide, was markedly enhanced by phenobarbitone and reduced by primaquine and cimetidine. We conclude that due to its single pathway of metabolism, tolbutamide is a good substrate to use when examining pharmacokinetic interactions involving hepatic enzyme induction and inhibition.This publication has 27 references indexed in Scilit:
- Effect of cimetidine on acetaminophen pharmacokinetics in ratsInternational Journal of Pharmaceutics, 1982
- Cimetidine inhibits microsomal drug metabolism in the ratEuropean Journal of Pharmacology, 1979
- Studies on the Different Metabolic Pathways of Antipyrine in Rats: Influence of Phenobarbital and 3-Methylcholanthrene TreatmentXenobiotica, 1979
- Interaction of Cimetidine with Liver MicrosomesXenobiotica, 1979
- Drug Interactions with Oral Sulphonylurea Hypoglycaemic DrugsDrugs, 1977
- Structure-activity relationships in the effects of 1-alkylimidazoles on microsomal oxidation in vitro and in vivoBiochemical Pharmacology, 1974
- Kinetics of drug-drug interactionsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- The Effect of Spironolactone on Antipyrine Metabolism in ManPharmacology, 1973
- Norphenazone, a new metabolite of phenazone in human urineJournal of Pharmacy and Pharmacology, 1973
- SULPHAPHENAZOLE-INDUCED HYPOGLYCÆMIC ATTACKS IN TOLBUTAMIDE-TREATED DIABETICSThe Lancet, 1963